Patents full text · MLC-0201
CPC subclass C07K
Peptides
| No. | Publication | Title | Published | Assignee |
|---|---|---|---|---|
| 1 | US2026104418A1 | Claudin18 antibodies and methods of treating cancer | 2026-04-16 | |
| 2 | US2026103696A1 | Compositions and methods for adoptive cell therapy for cancer | 2026-04-16 | |
| 3 | US2026103542A1 | Process of purification of protein | 2026-04-16 | |
| 4 | US2026103540A1 | Multispecific antigen-binding molecules having blood coagulation factor viii (fviii) cofactor function-substituting activity and pharmaceutical formulations containing such a molecule as an active ingredient | 2026-04-16 | |
| 5 | US2026103539A1 | Multispecific antigen binding proteins for tumor-targeting of NK cells and use thereof | 2026-04-16 | |
| 6 | US2026103529A1 | Amino Acid Sequences Directed Against the Melanocortin 4 Receptor and Polypeptides Comprising the Same for the Treatment of MC4R-Related Diseases and Disorders | 2026-04-16 | |
| 7 | US2026103524A1 | Nkg2d-nkp46 cell adapter molecule and use thereof | 2026-04-16 | |
| 8 | US2026103514A1 | Antibodies that specifically bind cldn6 or cd3 and bispecific antibodies that specifically bind cldn6 and cd3 | 2026-04-16 | |
| 9 | US2026103507A1 | Nucleic acid construct and use thereof | 2026-04-16 | |
| 10 | US2026103502A1 | Chimeric Antigen Receptor and Natural Killer Cells Expressing Same | 2026-04-16 | |
| 11 | US2026103494A1 | Gene therapy treatment | 2026-04-16 | |
| 12 | US2026102527A1 | CD8B-binding polypeptides | 2026-04-16 | |
| 13 | US2026102516A1 | Capsid variants and methods of using the same | 2026-04-16 | |
| 14 | US2026102507A1 | Camptothecin derivative for treating or preventing cancer and antibody-drug conjugate thereof | 2026-04-16 | |
| 15 | US2026102485A1 | Neutralizing anti-tl1a monoclonal antibodies | 2026-04-16 | |
| 16 | US2026102446A1 | Use of oncolytic viruses, alone or in combination with a checkpoint inhibitor, for the treatment of cancer | 2026-04-16 | |
| 17 | US2026102435A1 | Engineered cells and implantable elements for treatment of disease | 2026-04-16 | |
| 18 | US2022396796A1 | Rna for cancer therapy | 2022-12-15 | CUREVAC AG |
| 19 | US10718031B1 | Method and system for matching entities in an auction | 2020-07-21 | WU WAI |
| 20 | US10352897B2 | Expanding cam lock for sealing slab gels in an electrophoresis apparatus | 2019-07-16 | LIFE TECHNOLOGIES CORP |
| 21 | US10266809B2 | Polymer suitable for use in cell culture | 2019-04-23 | STICHTING KATHOLIEKE UNIV |
| 22 | US10190134B2 | Compositions and methods for insecticidal control of stinkbugs | 2019-01-29 | DU PONT |
| 23 | US2018273597A1 | Compositions and methods relating to the treatment of diseases | 2018-09-27 | ALFACYTE LTD |
| 24 | US9541004B2 | Antagonist antibodies against EphB3 | 2017-01-10 | NOVARTIS AG |
| 25 | US9441016B2 | Complete genome sequence of the methanogen Methanobrevibacter ruminantium | 2016-09-13 | ALTERMANN ERIC HEINZ |
| 26 | US9018160B2 | Peptide tyrosine tyrosine analogues | 2015-04-28 | BLOOM STEPHEN ROBERT |
| 27 | US8961969B2 | Antagonist antibodies against EphB3 | 2015-02-24 | NOVARTIS AG |
| 28 | US8383769B2 | Peptides for inhibiting chemokine binding to chemokine receptors | 2013-02-26 | BIOKINE THERAPEUTICS LTD |
| 29 | US8039440B2 | Peptides for inhibiting chemokine binding to chemokine receptors | 2011-10-18 | BIOKINE THERAPEUTICS LTD |
| 30 | US2011171213A1 | Methods for treating pancreatic cancer | 2011-07-14 | HOUHOU LEILA |
| 31 | US2011117086A1 | Monoclonal antibodies to progastrin and their uses | 2011-05-19 | BIOREALITES S A S |
| 32 | US2010008938A1 | Self assembling amphiphilic polymers as antiviral agents | 2010-01-14 | DIWAN ANIL |
| 33 | US2009265815A1 | Sequence-determined DNA fragments and corresponding polypeptides encoded therapy | 2009-10-22 | ALEXANDROV NICKOLAI |
| 34 | US2008045472A1 | Targets for human micro rnas in avian influenza virus (h5n1) genome | 2008-02-21 | COUNCIL SCIENT IND RES |
| 35 | US2006094652A1 | Hybrid polypeptides with selectable properties | 2006-05-04 | LEVY ODILE E |
| 36 | US2005287148A1 | Monoclonal antibody 1A7 and use for the treatment of melanoma and small cell carcinoma | 2005-12-29 | CHATTERJEE MALAYA |
| 37 | US2005136049A1 | Binding constructs and methods for use thereof | 2005-06-23 | |
| 38 | US6777537B1 | Osteoclast proton pump subunit | 2004-08-17 | FORSYTH DENTAL INFIRMARY |
| 39 | US6767991B1 | Hepatitis C inhibitor peptides | 2004-07-27 | BOEHRINGER INGELHEIM CA LTD |
| 40 | US6756354B2 | Therapeutic compositions containing oligo (ethylene glycol)-terminated 1,2-dithiolanes and their conjugates | 2004-06-29 | |
| 41 | US6608027B1 | Macrocyclic peptides active against the hepatitis C virus | 2003-08-19 | BOEHRINGER INGELHEIM CA LTD |
| 42 | US6475778B1 | Differentiation enhancing factors and uses therefor | 2002-11-05 | DANA FARBER CANCER INST INC |
| 43 | US6436673B1 | Polynucleotides encoding a novel neuronal cell growth factor | 2002-08-20 | UNIV JOHNS HOPKINS MED |
| 44 | US6429291B1 | Hyaluronan receptor protein | 2002-08-06 | |
| 45 | US6410707B2 | Recombinant preparation of calcitonin fragments and use thereof in the preparation of calcitonin and related analogs | 2002-06-25 | BIONEBRASKA INC |
| 46 | US6410531B1 | Hepatitis C inhibitor tri-peptides | 2002-06-25 | BOEHRINGER INGELHEIM CA LTD |
| 47 | US2002046415A1 | Plant promoter sequences and methods of use thereof | 2002-04-18 | US AGRICULTURE |
| 48 | US6319494B1 | Chimeric chains for receptor-associated signal transduction pathways | 2001-11-20 | CELL GENESYS INC |
| 49 | US6287817B1 | Fusion proteins for protein delivery | 2001-09-11 | UNIV CASE WESTERN RESERVE |
| 50 | US6268207B1 | Enzymatic resolution of 1-amino-2-vinylcyclopropyl caboxylic acid methyl ester | 2001-07-31 | BOEHRINGER INGELHEIM CA LTD |
| 51 | US6261820B1 | Fibronolytically active polypeptide | 2001-07-17 | AMGEN INC |
| 52 | US6228599B1 | Antibody specific for homogalacturonan | 2001-05-08 | DANISCO |
| 53 | US6165792A | Amino acid transporters | 2000-12-26 | DU PONT |
| 54 | US6069231A | PR domain peptides | 2000-05-30 | JOLLA CANCER RES FOUND |
| 55 | US6060057A | Cloning and sequencing of allergens of Dermatophagoides (house dust mite) | 2000-05-09 | IMMULOGIC PHARMA CORP |
| 56 | US6028189A | Solvent for oligonucleotide synthesis and methods of use | 2000-02-22 | UNIV WASHINGTON |
| 57 | US6025137A | Compositions and methods for the diagnosis, prevention and treatment of tumor progression | 2000-02-15 | MILLENNIUM PHARM INC |
| 58 | US5959098A | Substrate preparation process | 1999-09-28 | AFFYMETRIX INC |
| 59 | US5879672A | Tie-2 ligand 1 | 1999-03-09 | REGENERON PHARMA |
| 60 | US5780448A | DNA-based vaccination of fish | 1998-07-14 | OTTAWA CIVIC HOSPITAL LOEB RES |
| 61 | US5766866A | Lymphocyte chemoattractant factor and uses thereof | 1998-06-16 | RES CORP TECHNOLOGIES INC |
| 62 | US5763169A | Nucleic acid probes for the detection and identification of fungi | 1998-06-09 | CHIRON DIAGNOSTICS CORP |
| 63 | US5747034A | Methods and materials for the induction of T cell anergy | 1998-05-05 | CHIRON CORP |
| 64 | US5741462A | Remotely programmable matrices with memories | 1998-04-21 | IRORI |
| 65 | US5707802A | Nucleic acid probes for the detection and identification of fungi | 1998-01-13 | CIBA CORNING DIAGNOSTICS CORP |
| 66 | US5650297A | DNA encoding human colony-stimulating factors | 1997-07-22 | OTSUKA PHARMA CO LTD |
| 67 | US5624821A | Antibodies with altered effector functions | 1997-04-29 | SCOTGEN BIOPHARMACEUTICALS INC |
| 68 | US5547933A | Production of erythropoietin | 1996-08-20 | KIRIN AMGEN INC |
| 69 | US5506102A | Methods of using the A form of the progesterone receptor to screen for antagonists of steroid intracellar receptor-mediated transcription | 1996-04-09 | LIGAND PHARM INC |
| 70 | US5449754A | Generation of combinatorial libraries | 1995-09-12 | H & N INSTR INC |
| 71 | US5378696A | Rapamycin esters | 1995-01-03 | AMERICAN HOME PROD |
| 72 | US5288852A | Human tumor necrosis factor polypeptides | 1994-02-22 | DAINIPPON PHARMACEUTICAL CO |
| 73 | US4965199A | Preparation of functional human factor VIII in mammalian cells using methotrexate based selection | 1990-10-23 | GENENTECH INC |
| 74 | US4833233A | Human serum albumin crystals and method of preparation | 1989-05-23 | NASA |
| 75 | US4676980A | Target specific cross-linked heteroantibodies | 1987-06-30 | US HEALTH |
| 76 | US4303649A | 1-Phenyl-2-aminoethanol derivatives | 1981-12-01 | ICI LTD |
| 77 | US4179337A | Non-immunogenic polypeptides | 1979-12-18 | DAVIS FRANK F |
| 78 | US3991184A | Agent for the care of skin | 1976-11-09 | KLUDAS MARTIN |
78 records in this listing. Patents full text (MLC-0201). Request the full dataset.